RSV Vaccination

RSV Mother & Infant Protection Program (RSV-MIPP)

A national immunisation program for mothers and babies will be established in 2025 to protect babies from Respiratory Syncytial Virus (RSV). The National RSV Mother and Infant Protection Program (RSV-MIPP) will offer immunisation products to pregnant women, and infants at increased risk of severe RSV.

Vaccination for pregnant women

A single dose of the RSV vaccine, Abrysvo®, will be provided to pregnant women who are between 28-36 weeks into their pregnancy under the National Immunisation Program (NIP) from 3 February 2025. Maternal RSV vaccine is administered to protect newborn infants, through the passing of RSV-specific antibodies from the mother to the unborn baby.

Most UFS pharmacies are now offering the RSV vaccine. Please go to the Pharmacy Bookings page to make an appointment.